NEW YORK, NY, December 18, 2023 – Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements. Mind Medicine (MindMed) Inc. Robert Barrow, Chief Executive Officer and Director … Continue reading “MindMed Advances Treatment for Generalized Anxiety Disorder”
Breaking News
Breaking News
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
Phoenix, AZ, December 18, 2023 – SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable…
December 18, 2023
Breaking News
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design
In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the…
December 16, 2023
Breaking News
PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023
New York, December 15, 2023 PRISM MediaWire – Weekly Press Resume Dec. 11 to Dec.…
December 15, 2023
Breaking News
“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial
NEW YORK, NY, December 15, 2023 – NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its…
December 15, 2023
Breaking News
CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange
Correcting number of shares in previous Press Release SinglePoint, Inc. common stock to begin trading…
December 15, 2023
Breaking News
SinglePoint, Inc.–The Inaugural US Company to List on Cboe BZX Exchange
SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023,…
December 15, 2023
Breaking News
Verde Bio Holdings Announces Entry Into Business Combination Agreement with SensaSure Technologies, Inc.
Transaction will provide Formation Minerals Inc., a wholly-owned subsidiary of SensaSure Technologies, Inc. (OTCQB: SSTC)…
December 15, 2023
Breaking News
SinglePoint Announces Pricing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split
Phoenix, AZ, December 15, 2023 – SinglePoint Inc. formerly (OTC: SING) now trades as (Cboe:…
December 15, 2023
Breaking News
PRISM AdTech & Media Company Spotlight: Creative Realities (CREX) Illuminates the Future of Experiential Design
NEW YORK, NY, December 14, 2023 – In the fast-paced landscape of experiential design and…
December 14, 2023
Breaking News
Center for Medicare Services Established National Pricing of AmnioWrap2 (TM) in All MAC Regions
Pricing Provides AmnioWrap2TM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA, December 14, 2023 –…
December 14, 2023
Breaking News
Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024
– Sales Grew 58% YOY; Backlog Grew 68% YOY and Remains Strong at $10.4 Million;…
December 14, 2023
Breaking News
PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation
NEW YORK, NY, December 13, 2023 – US equities closed mostly higher on Tuesday as…
December 13, 2023
Breaking News
FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%
NEW YORK, NY, December 13, 2023 – ReShape Lifesciences (Nasdaq: RSLS) has been granted FDA approval of a PMA…
December 13, 2023